11 – 20 of 85
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Relationships between uptake of [68Ga]Ga-DOTA-TATE and absorbed dose in [177Lu]Lu-DOTA-TATE therapy
(
- Contribution to journal › Article
-
Mark
Phase II trial demonstrates the efficacy and safety of individualized, dosimetry-based 177Lu-DOTATATE treatment of NET patients
(
- Contribution to journal › Article
-
Mark
EANM dosimetry committee recommendations for dosimetry of 177Lu-labelled somatostatin-receptor- and PSMA-targeting ligands
(
- Contribution to journal › Article
- 2021
-
Mark
Computational and experimental methods for imaging and dosimetry in 177Lu radionuclide therapy : Classical and novel gamma cameras
2021)(
- Thesis › Doctoral thesis (compilation)
-
Mark
EANM position paper on article 56 of the Council Directive 2013/59/Euratom (basic safety standards) for nuclear medicine therapy
(
- Contribution to journal › Article
-
Mark
Monitoring electron energies during FLASH irradiations
(
- Contribution to journal › Article
-
Mark
Optically stimulated luminescence dosimetry with NaCl pellets. Dosimetry for prospective applications
2021) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
Establishment and Initial Experience of Clinical FLASH Radiotherapy in Canine Cancer Patients
(
- Contribution to journal › Article
-
Mark
Perspectives on interstitial photodynamic therapy for malignant tumors
(
- Contribution to journal › Scientific review
-
Mark
Kidney protection with the radical scavenger α1-microglobulin (A1m) during peptide receptor radionuclide and radioligand therapy
(
- Contribution to journal › Article